Efficacy and tolerability of systemic methylprednisolone in children and adolescents with chronic rhinosinusitis: A double-blind, placebo-controlled randomized trial Fadıl Ozturk, MD, Arzu Bakirtas, MD, Fikret Ileri, MD, Ipek Turktas, MD Journal of Allergy and Clinical Immunology Volume 128, Issue 2, Pages 348-352 (August 2011) DOI: 10.1016/j.jaci.2011.04.045 Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Mean change from baseline in symptom and CT scan scores. Columns and error bars represent means and 95% CIs. CS, Cough score (P = .009); CTS, CT scan score (P = .004); H/FPS, headache or facial pain score (P > .05); HS, halitosis score (P > .05); MP, methylprednisolone; NDS, nasal discharge score (P > .05); NOS, nasal obstruction score (P = .001); P, placebo; PDS, postnasal discharge score (P = .007); TSS, total symptom score (P = .001). Journal of Allergy and Clinical Immunology 2011 128, 348-352DOI: (10.1016/j.jaci.2011.04.045) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions